Have a personal or library account? Click to login
Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line Cover

Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line

Current Issues in Pharmacy and Medical Sciences
Volume 32 (2019): Issue 2 (June 2019)
By: Agnieszka Korga,  Ewelina Humeniuk,  Grzegorz Adamczuk,  Magdalena Iwan,  Marta Ostrowska,  Iwona Luszczewska-Sierakowska and  Jarosław Dudka  
Open Access
|Jul 2019

Authors

Agnieszka Korga

agnieszka.korga@umlub.pl

Independent Medical Biology Unit, Medical University of Lublin, Poland

Ewelina Humeniuk

Chair and Department of Toxicology, Medical University of Lublin, Poland

Grzegorz Adamczuk

Chair and Department of Toxicology, Medical University of Lublin, Poland

Magdalena Iwan

Independent Medical Biology Unit, Medical University of Lublin, Poland

Marta Ostrowska

Chair and Department of Toxicology, Medical University of Lublin, Poland

Iwona Luszczewska-Sierakowska

Department of Normal Anatomy, Medical University of Lublin, Poland

Jarosław Dudka

Chair and Department of Toxicology, Medical University of Lublin, Poland
DOI: https://doi.org/10.2478/cipms-2019-0017 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 87 - 91
Submitted on: Sep 21, 2018
|
Accepted on: Nov 12, 2018
|
Published on: Jul 2, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
doxorubicin,
bortezomib,
lymphoblastic leukemia,
oxidative stress
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2019 Agnieszka Korga, Ewelina Humeniuk, Grzegorz Adamczuk, Magdalena Iwan, Marta Ostrowska, Iwona Luszczewska-Sierakowska, Jarosław Dudka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 32 (2019): Issue 2 (June 2019)Next article